Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits
If finalized, the agreement, along with a companion deal reached by Teva earlier this week, would send as much as $6.6 billion to communities harmed by the opioid epidemic.
View original article
Contributor: Jan Hoffman
